<DOC>
	<DOCNO>NCT00591799</DOCNO>
	<brief_summary>The purpose study determine safety effectiveness Jarvik 2000 Heart bridge heart transplantation end-stage heart failure patient approve heart transplant candidate .</brief_summary>
	<brief_title>Jarvik 2000 Heart Bridge Cardiac Transplantation - Pivotal Trial</brief_title>
	<detailed_description>The Jarvik 2000 Heart silent compact axial flow impeller pump 1 inch diameter , weigh 90g displacement volume 25ml . The pump implant apex left ventricle leave thoracotomy , mid-sternotomy , subcostal approach . A vascular graft offloads either descend thoracic aorta , ascend thoracic aorta , abdominal aorta . The impeller rotate speed 8,000 12,000 rpm provide blood flow seven L/minute . At high speed pump produce 10 L/minute . Power provide abdominal drive line .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>( The follow general inclusion criterion ; specific criterion outline study protocol ) . Transplant list UNOS status IA IB patient . BSA &gt; 1.5 m2 &lt; 2.3 m2 . Dependent one intravenous inotropic agent intraaortic balloon pump ( IABP ) . ( The follow general exclusion criterion ; specific criterion outline study protocol ) . Known risk factor condition would contraindicate LVAD implantation adversely affect patient survival . Evidence end organ dysfunction . Known coagulopathy contraindication anticoagulation antiplatelet agent . Systemic infection . Malignancies remission . Current participation investigational trial device , drug , biologic agent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>